Indeed MI mice, treated with 30 mg/kg/day of hesperetin for 8 weeks, showed impaired NF-κB activation, reduced cardiac fibrosis and inflammation compared to untreated MI-mice [200]. This evidence concerns the gene NFKB1 and myocardial infarction.